A phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrence esophageal cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Jul 2010
At a glance
- Drugs Capecitabine (Primary) ; Paclitaxel (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 08 Jul 2010 Planned end date changed from 1 Dec 2009 to 1 Dec 2010 as reported by ClinicalTrials.gov.
- 03 Nov 2009 Actual patient number (33) added as reported by ClinicalTrials.gov.
- 03 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.